Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts

Is Metformin recalled?

Yes — there is an active recall. 23 ongoing FDA recalls mention Metformin (91 total). Check the affected lots below.

Recalls are matched by product description. A recall usually affects specific lots, not every package of Metformin. “Active” means an FDA recall is still ongoing; “closed” means it was terminated or completed. Checked against openFDA on Oct 10, 2026.

Metformin recalls on record

none so far in 2026; 91 on record, newest first
Class II · Moderate risk

Metformin Hydrochloride Tablets

Presence of Foreign Tablets/Capsules; report of Amlodipine Tablets found in 1000 count bottles of Metformin Hydrochloride Tablets USP

Terminated Particulate / foreign matter Ascend Laboratories LLC NDC 67877-217-10 D-0163-2017
Class III · Low risk

Invokamet (canagliflozin and metformin HCl)

Labeling: Incorrect or Missing Package Insert - Xarelto prescribing information outserts may be affixed to the exterior of Invokamet bottles in place of the Invokamet prescribing information outsert.

Terminated Labeling / mix-up Janssen Ortho L.L.C. NDC 50458-543-60 D-0115-2017
Class II · Moderate risk

Metformin HCl active pharmaceutical ingredient packaged in…

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Terminated Cross-contamination Attix Pharmaceuticals D-781-2015
Class II · Moderate risk

Metformin Hydrochloride USP

CGMP Deviations: The Active Pharmaceutical Ingredient was not manufactured according to current good manufacturing practices.

Terminated cGMP deviation Betachem, Inc. D-406-2014
Class II · Moderate risk

metFORMIN HCl Tablet 500 mg

Labeling: Label Mixup; metFORMIN HCl Tablet, 500 mg may be potentially mislabeled as OMEGA-3 FATTY ACID, Capsule, 1000 mg, NDC 40985022921, Pedigree: AD32742_1, EXP: 5/1/2014.

Terminated Labeling / mix-up Aidapak Services, LLC D-528-2014
Class II · Moderate risk

Kombiglyze XR

Labeling; Correct labeled product miscart/mispack: Some Physician sample cartons were incorrectly labeled as Kombiglyze XR 2.5mg/1000mg on the external package carton, whereas the contents were Kombiglyze XR 5 mg/500 mg blister packaged tablets. The individual blister units are labeled correctly.

Terminated Labeling / mix-up Bristol-myers Squibb Company D-019-2013
Class II · Moderate risk

Kombiglyze XR

Labeling; Correct labeled product miscart/mispack: Some Physician sample cartons were incorrectly labeled as Kombiglyze XR 2.5mg/1000mg on the external package carton, whereas the contents were Kombiglyze XR 5 mg/500 mg blister packaged tablets. The individual blister units are labeled correctly.

Terminated Labeling / mix-up Bristol-myers Squibb Company D-018-2013
Class II · Moderate risk

Metformin Hydrochloride Tablets

Presence of Foreign Substance(s): A product complaint was received from a pharmacist who discovered that several tablets displayed brown specks. The same complainant also reported that metal shaving like material was observed on the surface of one tablet.

Terminated Particulate / foreign matter Zydus Pharmaceuticals USA Inc NDC 68382-030-10 D-1428-2012
Class I · High risk

metFORMIN ER Tablets

Labeling: Label Mix up; product labeled did not indicated Extended Release

Terminated Labeling / mix-up Shamrock Medical Solutions Group LLC NDC 53746-178-01 D-1448-2014